Log In
Print this Print this


Also known as: P2B 001

  Manage Alerts
Collapse Summary General Information
Company Pharma Two B Ltd.
DescriptionOral fixed-dose combination of pramipexole, a dopamine agonist, and rasagiline, an irreversible selective inhibitor of monoamine oxidase B (MAO-B)
Molecular Target Monoamine oxidase B (MAO-B) ; Dopamine receptor
Mechanism of ActionDopamine D2 receptor agonist; Dopamine D3 receptor agonist; Monoamine oxidase B (MAO-B) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationParkinson's disease (PD)
Indication DetailsTreat early stage Parkinson's disease (PD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today